The CFTC recently greenlighted Kalshi’s plan to list perps in the U.S. CME, the dominant derivatives exchange, argued the regulator violated federal law.
The CFTC recently greenlighted Kalshi’s plan to list perps in the U.S. CME, the dominant derivatives exchange, argued the regulator violated federal law.